PDE11

Cyclic Nucleotide Phosphodiesterases in Health and Disease

Volumn , Issue , 2006, Pages 255-274

  Omori, Kenji ^a   Kotera, Jun ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950194782     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (41)

1. Beavo, J.A., and L.L. Brunton. 2002. Cyclic nucleotide research-Still expanding after half a century. Nat Rev Mol Cell Biol 3:710.
2. Houslay, M.D., and G. Milligan. 1997. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem Sci 22:217.
3. Soderling, S.H., and J.A. Beavo. 2000. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions. Curr Opin Cell Biol 12:174.
4. Lucas, K.A., et al. 2000. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52:375.
5. Watts, V.J. 2002. Molecular mechanisms for heterologous sensitization of adenylate cyclases. J Pharmacol Exp Ther 302:1.
6. Beavo, J.A. 1995. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 75:724.
7. Francis, S.H., I.V. Turko, and J.D. Corbin. 2001. Cyclic nucleotide phosphodiesterases: Relating structure and function. Prog Nucleic Acid Res Mol Biol 65:1.
8. Houslay, M.D. 2001. PDE4 cAMP-specific phosphodiesterases. Prog Nucleic Acid Res Mol Biol 69:249.
9. Michel, J.J., and J.D. Scott. 2002. AKAP mediated signal transduction. Annu Rev Pharmacol Toxicol 42:235.
10. Aravind, L., and E.V. Koonin. 1998. The HD domain defines a new superfamily of metal-dependent phosphohydrolases. Trends Biochem Sci 23:469.
11. Aravind, L., and C.P. Ponting. 1997. The GAF domain: An evolutionary link between diverse phototransducing proteins. Trends Biochem Sci 22:458.
12. Yuasa, K., et al. 2001. Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains. Eur J Biochem 268:168.
13. Fawcett, L., et al. 2000. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci USA 97:3702.
14. Hetman, J.M., et al. 2000. Cloning and characterization of two splice variants of human phosphodiesterase 11A. Proc Natl Acad Sci USA 97:12891.
15. Yuasa, K., et al. 2000. Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression. J Biol Chem 275:31469.
16. Yuasa, K., et al. 2001. Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): Comparison of rat and human PDE11A splicing variants. Eur J Biochem 268:4440.
17. Weeks, J.L., et al. 2005. High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients. Int J Impot Res 17:5.
18. Fujishige, K., et al. 1999. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). J Biol Chem 274:18438.
19. Gross-Langenhoff, M., et al. 2006. cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11. J Biol Chem 281:2841.
20. D'Andrea, M.R., et al. 2005. Expression of PDE11A in normal and malignant human tissues. J Histochem Cytochem 53:895.
21. Gebkor, E., et al. 2002. Selectivity of sildenafil and other phosphodiesterase type 5 (PDE5) inhibitors against all human phosphodiesterase families. Eur Urol 1 (Suppl. 1):63.
22. Degerman, E., P. Belfrage, and V.C. Manganiello. 1997. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 272:6823.
23. Lim, J., G. Pahlke, and M. Conti. 1999. Activation of the cAMP-specific phosphodiesterase PDE4D3 by phosphorylation: Identification and function of an inhibitory domain. J Biol Chem 274:19677.
24. Corbin, J.D., et al. 2000. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activity. Eur J Biochem 267:2760.
25. Sharma, R.K., and J.H. Wang. 1985. Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase. Proc Natl Acad Sci USA 82:2603.
26. Kotera, J., et al. 2004. Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation. J Biol Chem 279:4366.
27. Wayman, C., et al. 2005. Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology. Int J Impot Res 17:216.
28. Baxendale, R.W., F. Burslem, and S.C. Phillips. 2001. Phosphodiesterase type 11 (PDE11) cellular localization: Progress towards defining a physiological role in testis and/or reproduction. J Urol 165 (Suppl.):340.
29. Baxendale, R.W., et al. 2001. Cellular localization of phosphodiesterase type 11 (PDE11) in human corpus cavernosum and the contribution of PDE11 inhibition on nerve-stimulated relaxation. J Urol 165 (Suppl.):233.
30. Uckert, S., et al. 2004. Immunohistochemical presence of phophodiesterase (PDE) 11A in the human prostate. J Urol 171 (Suppl.):352.
31. Loughney, K., J. Taylor, and V.A. Florio. 2005. 3',5'-Cyclic nucleotide phosphodiesterase 11A: Localization in human tissues. Int J Impot Res 17:320.
32. Fujishige, K., et al. 2000. The human phosphodiesterase PDE10A gene genomic organization and evolutionary relatedness with other PDEs containing GAF domains. Eur J Biochem 267:5943.
33. Heinemeyer, T., et al. 1999. Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. Nucleic Acids Res 27:318.
34. Gubbay, J., et al. 1990. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 346:245.
35. Denny, P., et al. 1992. An SRY-related gene expressed during spermatogenesis in the mouse encodes a sequence-specific DNA-binding protein. EMBO J 11:3705.
36. Lassar, A.B., et al. 1989. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 58:823.
37. Riegman, P.H.J., et al. 1991. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 5:192.
38. Nantel, F., et al. 1996. Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice. Nature 380:159.
39. Hellstrom, W.J., et al. 2003. Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones. J Urol 170:887.
40. Pomara, G., et al. 2004. Effect of acute in vivo sildenafil and tadalafil treatments on semen parameters in patients with fertility problem, a randomized double-blind, cross over study. J sex Med 2 (suppl. 2):23.
41. Francis, S.H. 2005. Phosphodiesterase 11 (PDE11): Is it a player in human testicular function? Int J Impot Res 17:467.